Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractio

  • PDF / 534,875 Bytes
  • 8 Pages / 595.276 x 790.866 pts Page_size
  • 59 Downloads / 216 Views

DOWNLOAD

REPORT

RESEARCH

Open Access

Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy Stefano Bracci*, Mattia F. Osti, Linda Agolli, Luca Bertaccini, Vitaliana De Sanctis and Maurizio Valeriani

Abstract Background: to evaluate the role of a risk stratification system in intermediate-risk prostate cancer (PCa) treated with hypofractionated radiotherapy (HyRT). Methods: 131 patients affected by intermediate-risk PCa were treated with HyRT at the total dose of 54,75 Gy in 15 fraction plus 9 months of androgen deprivation therapy (ADT). Patients were classified as favourable risk (FIR) if they had a single NCCN intermediate-risk factor (IRF), a Gleason score ≤3 + 4 = 7, and

Data Loading...

Recommend Documents
Favourable long-term survival of patients with esophageal cancer treated with extended transhiatal esophagectomy combine

154 46 708KB

Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated wit

164 68 229KB

Favorable outcomes in locally advanced and node positive prostate cancer patients treated with combined pelvic IMRT and

147 88 620KB

Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiothe

141 28 832KB

PPI use affects outcomes in urothelial cancer treated with atezolizumab

141 60 148KB

Clinical outcomes in elderly rectal cancer patients treated with neoadjuvant chemoradiotherapy: impact of tumor regressi

142 26 1001KB

The Problem of Underrepresentation: Black Participants in Lifestyle Trials Among Patients with Prostate Cancer

127 12 490KB

Language impairment among patients with different types of cancer. Comparison with healthy adults

122 25 400KB

Antiresorptive agent-related osteonecrosis of the jaw in prostate cancer patients with bone metastasis treated with bone

168 9 702KB

Clinical presentations and outcomes in pulmonary embolism patients with cancer

167 72 497KB

COVID-19 and Cardiovascular Health Among Patients with Cancer

201 39 2MB

Letter to the Editor: No immunophenotyping in peripheral blood of prostate cancer patients treated with neoadjuvant Ritu

129 45 584KB